These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6322065)

  • 1. Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation.
    Jolicoeur FB; De Michele G; Barbeau A; St-Pierre S
    Neurosci Biobehav Rev; 1983; 7(3):385-90. PubMed ID: 6322065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing.
    Jolicoeur FB; Gagne MA; Rivest R; Drumheller A; St-Pierre S
    Pharmacol Biochem Behav; 1991 Feb; 38(2):463-5. PubMed ID: 2057514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical neuroleptic-like behavioral effects of neurotensin.
    Jolicoeur FB; Gagné MA; Rivest R; Drumheller A; St-Pierre S
    Brain Res Bull; 1993; 32(5):487-91. PubMed ID: 8106129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change.
    Hiroi N; White NM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):249-58. PubMed ID: 2543991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of estrogen on apomorphine-induced hypothermia and stereotypy in the rat.
    Pittman KJ; Fibiger HC
    Neuropharmacology; 1983 May; 22(5):587-92. PubMed ID: 6683792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomifensine: a potent dopaminergic agonist of antiparkinson potential.
    Costall B; Kelly DM; Naylor RJ
    Psychopharmacologia; 1975; 41(2):153-64. PubMed ID: 1098084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs.
    Dougherty GG; Ellinwood EH
    Physiol Behav; 1983 Apr; 30(4):607-12. PubMed ID: 6683846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.
    Poncelet M; Souilhac J; Gueudet C; Terranova JP; Gully D; Le Fur G; Soubrié P
    Psychopharmacology (Berl); 1994 Oct; 116(2):237-41. PubMed ID: 7862953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
    Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.